BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37257200)

  • 21. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS; Yang Q; Haffty BG
    Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Single-Agent Chemotherapy for Patients with Advanced Invasive Lobular Carcinoma: A Pooled Analysis from Three Clinical Trials.
    Pérez-Garcia J; Cortés J; Metzger Filho O
    Oncologist; 2019 Aug; 24(8):1041-1047. PubMed ID: 30578311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes.
    Engstrøm MJ; Opdahl S; Vatten LJ; Haugen OA; Bofin AM
    Histopathology; 2015 Feb; 66(3):409-19. PubMed ID: 25283075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
    Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast.
    Korhonen T; Huhtala H; Holli K
    Breast Cancer Res Treat; 2004 May; 85(1):23-9. PubMed ID: 15039595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lobular Breast Cancer and Abdominal Metastases: A Retrospective Review and Impact on Survival.
    Winn JS; Baker MG; Fanous IS; Slack-Davis JK; Atkins KA; Dillon PM
    Oncology; 2016; 91(3):135-42. PubMed ID: 27355204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers.
    Mamtani A; Zabor EC; Stempel M; Morrow M
    Ann Surg Oncol; 2019 Oct; 26(10):3269-3274. PubMed ID: 31342363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.
    Rakha EA; El-Sayed ME; Powe DG; Green AR; Habashy H; Grainge MJ; Robertson JF; Blamey R; Gee J; Nicholson RI; Lee AH; Ellis IO
    Eur J Cancer; 2008 Jan; 44(1):73-83. PubMed ID: 18035533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer.
    Sahin S; Karatas F; Erdem GU; Hacioglu B; Altundag K
    Am Surg; 2017 Apr; 83(4):359-364. PubMed ID: 28424130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.
    Arpino G; Bardou VJ; Clark GM; Elledge RM
    Breast Cancer Res; 2004; 6(3):R149-56. PubMed ID: 15084238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
    Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
    Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.
    Rothschild HT; Clelland EN; Mujir F; Record H; Wong J; Esserman LJ; Alvarado M; Ewing C; Mukhtar RA
    Ann Surg Oncol; 2023 Oct; 30(10):5999-6006. PubMed ID: 37464134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population.
    Cao AY; Huang L; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM; Di GH
    World J Surg Oncol; 2012 Jul; 10():152. PubMed ID: 22805492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
    Ping Z; Siegal GP; Harada S; Eltoum IE; Youssef M; Shen T; He J; Huang Y; Chen D; Li Y; Bland KI; Chang HR; Shen D
    Oncotarget; 2016 Dec; 7(49):80655-80663. PubMed ID: 27811364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.
    Da Ros L; Moretti A; Querzoli P; Pedriali M; Lupini L; Bassi C; Carcoforo P; Negrini M; Frassoldati A
    Clin Breast Cancer; 2018 Oct; 18(5):e1133-e1139. PubMed ID: 29759595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
    Bharat A; Gao F; Margenthaler JA
    Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
    Sinha PS; Bendall S; Bates T
    Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer.
    Van Baelen K; Nguyen HL; Hamy-Petit AS; Richard F; Karsten MM; Nader Marta G; Vermeulen P; Toussaint A; Reyal F; Vincent-Salomon A; Dirix L; Dordevic AD; de Azambuja E; Larsimont D; Amato O; Maetens M; De Schepper M; Geukens T; Han SN; Baert T; Punie K; Wildiers H; Smeets A; Nevelsteen I; Floris G; Biganzoli E; Neven P; Desmedt C
    Eur J Cancer; 2023 Sep; 191():112988. PubMed ID: 37573673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of neighborhood social disadvantage on the presentation and management of peripheral artery disease.
    Mota L; Marcaccio CL; Zhu M; Moreira CC; Rowe VL; Hughes K; Liang P; Schermerhorn ML
    J Vasc Surg; 2023 May; 77(5):1477-1485. PubMed ID: 36626955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?
    Silverstein MJ; Lewinsky BS; Waisman JR; Gierson ED; Colburn WJ; Senofsky GM; Gamagami P
    Cancer; 1994 Mar; 73(6):1673-7. PubMed ID: 8156495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.